University of Wisconsin-Madison, in a statement: “This proposed change to NIH funding – UW–Madison’s largest source of federal support – will significantly disrupt vital research activity and delay lifesaving discoveries and cures related to cancer, Alzheimer’s disease, diabetes, and much more.
“In addition, these reductions will have an inevitable impact on student opportunities to engage in research activities, from undergraduates to Ph.D. and medical students. Medical innovation will be slowed, delaying the creation of new treatments, new technologies, and new health workers.”